GemPharmatech Co Ltd
SSE:688046
Wall Street
Price Targets
Price Targets Summary
GemPharmatech Co Ltd
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GemPharmatech Co Ltd's stock price target?
Not Available
GemPharmatech Co Ltd doesn't have any price targets made by Wall Street professionals.
What is GemPharmatech Co Ltd's Revenue forecast?
Projected CAGR
15%
For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's revenue is 29%. The projected CAGR for the next 2 years is 15%.
What is GemPharmatech Co Ltd's Operating Income forecast?
Projected CAGR
25%
For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 25%.
What is GemPharmatech Co Ltd's Net Income forecast?
Projected CAGR
41%
For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's net income is 26%. The projected CAGR for the next 2 years is 41%.